314 related articles for article (PubMed ID: 16763279)
21. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
[TBL] [Abstract][Full Text] [Related]
22. Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin.
Zakotnik B; Budihna M; Smid L; Soba E; Strojan P; Fajdiga I; Zargi M; Oblak I; Lesnicar H
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):685-90. PubMed ID: 17197122
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
Salama JK; Vokes EE; Chmura SJ; Milano MT; Kao J; Stenson KM; Witt ME; Haraf DJ
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):382-91. PubMed ID: 16213104
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of head and neck cancer with retinoids: a negative result.
Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
[TBL] [Abstract][Full Text] [Related]
25. Re-irradiation of head and neck cancer-impact of total dose on outcome.
Janssen S; Baumgartner M; Bremer M; Warszawski A; Stieve M; Eckardt A; Karstens JH; Meyer A
Anticancer Res; 2010 Sep; 30(9):3781-6. PubMed ID: 20944169
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant therapy in patients with resected poor-risk head and neck cancer.
Bernier J; Vermorken JB; Koch WM
J Clin Oncol; 2006 Jun; 24(17):2629-35. PubMed ID: 16763276
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?
Specenier PM; Vermorken JB
Cancer Lett; 2007 Oct; 256(2):166-77. PubMed ID: 17673364
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions.
Shin DM; Lippman SM
Semin Oncol; 1999 Feb; 26(1 Suppl 2):100-5. PubMed ID: 10190789
[TBL] [Abstract][Full Text] [Related]
30. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival following salvage reirradiation with concurrent chemotherapy for recurrent head and neck cancer.
Watkins JM; Stuart RK; Davis BK; Day TA; Chaudharry UB; Sharma AK
J S C Med Assoc; 2008 Feb; 104(2):36-9. PubMed ID: 18396601
[No Abstract] [Full Text] [Related]
32. Organ and function preservation: the role of surgery as the optimal primary modality or as salvage after chemoradiation failure.
Scher RL; Esclamado RM
Semin Radiat Oncol; 2009 Jan; 19(1):17-23. PubMed ID: 19028341
[TBL] [Abstract][Full Text] [Related]
33. Chemo re-irradiation in recurrent head and neck cancer: a single institution experience.
Katodritis N; Charalampous H; Vomvas D
J BUON; 2012; 17(2):397. PubMed ID: 22740226
[No Abstract] [Full Text] [Related]
34. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma.
Kasperts N; Slotman BJ; Leemans CR; de Bree R; Doornaert P; Langendijk JA
Cancer; 2006 Apr; 106(7):1536-47. PubMed ID: 16518815
[TBL] [Abstract][Full Text] [Related]
35. Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Cohen EE; Rosine D; Haraf DJ; Loh E; Shen L; Lusinchi A; Vokes EE; Bourhis J
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):678-84. PubMed ID: 17293229
[TBL] [Abstract][Full Text] [Related]
36. RADPLAT: an alternative to surgery?
Alkureishi LW; de Bree R; Ross GL
Oncologist; 2006 May; 11(5):469-80. PubMed ID: 16720847
[TBL] [Abstract][Full Text] [Related]
37. [Advances in the treatment of head and neck tumors. 2. Radiochemotherapy].
Stupp R; Vokes EE
Strahlenther Onkol; 1995 Mar; 171(3):140-8. PubMed ID: 7535952
[TBL] [Abstract][Full Text] [Related]
38. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
39. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
Roman E; Raez LE; Santos ES
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
[TBL] [Abstract][Full Text] [Related]
40. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
Nuyts S; Dirix P; Clement PM; Poorten VV; Delaere P; Schoenaers J; Hermans R; Van den Bogaert W
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1088-95. PubMed ID: 18707823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
